Canada Life’s Oric Pharmaceuticals ORIC Stock Holding History

Canada Life’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71K	Hold	5,593	–	–	﹤0.01%	1723
2025 Q4	$46K	Hold	5,593	–	–	﹤0.01%	1794
2025 Q3	$65K	Buy	+5,593	New	+$58.8K	﹤0.01%	1796
2025 Q2	–	Sell	-8,324	Closed	-$46K	–	1983
2025 Q1	$46K	Hold	8,324	–	–	﹤0.01%	1869
2024 Q4	$67K	Hold	8,324	–	–	﹤0.01%	1864
2024 Q3	$85K	Hold	8,324	–	–	﹤0.01%	1888
2024 Q2	$59K	Buy	+8,324	New	+$74.5K	﹤0.01%	1950
2022 Q2	–	Sell	-1,440	Closed	-$8K	–	2454
2022 Q1	$8K	Hold	1,440	–	–	﹤0.01%	2449
2021 Q4	$21K	Hold	1,440	–	–	﹤0.01%	2374
2021 Q3	$30K	Hold	1,440	–	–	﹤0.01%	2358
2021 Q2	$25K	Hold	1,440	–	–	﹤0.01%	2441
2021 Q1	$35K	Buy	1,440 +824	+134%	+$26K	﹤0.01%	2405
2020 Q4	$21K	Buy	+616	New	+$17.7K	﹤0.01%	2532

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Canada Life's ORIC Position: Q1 2026 in Review

Canada Life held its Oric Pharmaceuticals (ORIC) position steady in Q1 2026 at 5,593 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

Canada Life first reported a position in ORIC in Q4 2020 and has held it in 13 quarters since. The position peaked at $85K in Q3 2024. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Canada Life held 5,593 shares of Oric Pharmaceuticals worth $71K as of Q1 2026.
Canada Life left its Oric Pharmaceuticals share count unchanged in Q1 2026.
Oric Pharmaceuticals made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1723 holding.
Canada Life first reported a position in Oric Pharmaceuticals in Q4 2020 and has held it in 13 quarters since.
Canada Life's Oric Pharmaceuticals position peaked at $85K in Q3 2024.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.